Beta Bionics, Inc. · NASDAQ:BBNX
Lezack Adam sold 1,998 Beta Bionics, Inc. shares (Form 4)
Traded May 21 to May 22, 2026 · Filed May 26, 2026
From May 21 to May 22, 2026, Lezack Adam (Director) sold 1,998 Beta Bionics, Inc. shares at an average US$10.58 for US$21,138 under a trading plan, leaving 27,399 shares. Filed May 26, 2026 (Form 4).
- Sold
- 1,998 shares
- Price
- US$10.58 average (US$9.95 to US$11.21)
- Value
- US$21,138
- Holding after
- 27,399 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Sale | 1,000 | US$9.95 | 11,432 | Direct |
| May 21, 2026 | Common Stock | Award | 16,965 | 28,397 | Direct | |
| May 22, 2026 | Comon Stock | Sale | 998 | US$11.21 | 27,399 | Direct |